WCD 2019: Guselkumab Durably Effective in Psoriasis Patients After 3-Year Follow Up
Response rates were similarly high in multiple subgroups of patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Response rates were similarly high in multiple subgroups of patients
Only registered members have full access to PracticeUpdate content.